APA (7th ed.) Citation

Bastholt, L., Specht, L., Jensen, K., Brun, E., Loft, A., Petersen, J., . . . Eriksen, J. G. (2007). Phase I/II clinical and pharmacokinetic study evaluating a fully human monoclonal antibody against EGFr (HuMax-EGFr) in patients with advanced squamous cell carcinoma of the head and neck. Radiotherapy & Oncology, 85(1), 24. https://doi.org/10.1016/j.radonc.2007.06.007

Chicago Style (17th ed.) Citation

Bastholt, Lars, Lena Specht, Kenneth Jensen, Eva Brun, Annika Loft, Jørgen Petersen, Helle Kastberg, and Jesper G. Eriksen. "Phase I/II Clinical and Pharmacokinetic Study Evaluating a Fully Human Monoclonal Antibody Against EGFr (HuMax-EGFr) in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck." Radiotherapy & Oncology 85, no. 1 (2007): 24. https://doi.org/10.1016/j.radonc.2007.06.007.

MLA (9th ed.) Citation

Bastholt, Lars, et al. "Phase I/II Clinical and Pharmacokinetic Study Evaluating a Fully Human Monoclonal Antibody Against EGFr (HuMax-EGFr) in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck." Radiotherapy & Oncology, vol. 85, no. 1, 2007, p. 24, https://doi.org/10.1016/j.radonc.2007.06.007.